ArticleThoracic cancer2018

Survival analysis of patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi-center retrospective study.

Qingming Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.